Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperlipidemias | 3 | 2023 | 789 | 1.380 |
Why?
|
Antihypertensive Agents | 5 | 2022 | 2046 | 1.120 |
Why?
|
Hypertension | 8 | 2023 | 8480 | 1.050 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2021 | 2208 | 0.830 |
Why?
|
Eligibility Determination | 2 | 2022 | 403 | 0.820 |
Why?
|
Diabetes Mellitus | 5 | 2023 | 5751 | 0.790 |
Why?
|
Incretins | 1 | 2021 | 88 | 0.760 |
Why?
|
Glucagon-Like Peptides | 1 | 2021 | 127 | 0.760 |
Why?
|
Medicare Part C | 2 | 2022 | 296 | 0.760 |
Why?
|
Rural Health | 1 | 2021 | 305 | 0.690 |
Why?
|
Blood Pressure | 5 | 2022 | 8554 | 0.680 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2023 | 11725 | 0.670 |
Why?
|
Economics, Hospital | 1 | 2021 | 213 | 0.660 |
Why?
|
Urban Health | 1 | 2021 | 547 | 0.640 |
Why?
|
Anti-Obesity Agents | 1 | 2021 | 217 | 0.630 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2022 | 3255 | 0.620 |
Why?
|
Cardiovascular Diseases | 6 | 2023 | 15165 | 0.600 |
Why?
|
United States Food and Drug Administration | 2 | 2021 | 1584 | 0.570 |
Why?
|
Nutrition Surveys | 6 | 2023 | 1660 | 0.570 |
Why?
|
Heart Failure | 6 | 2023 | 10900 | 0.570 |
Why?
|
Atrial Fibrillation | 2 | 2024 | 5034 | 0.510 |
Why?
|
Glomerular Filtration Rate | 2 | 2021 | 2170 | 0.510 |
Why?
|
Drug Approval | 1 | 2021 | 742 | 0.500 |
Why?
|
United States | 22 | 2023 | 69872 | 0.490 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2020 | 1240 | 0.490 |
Why?
|
Cholesterol, LDL | 1 | 2023 | 2356 | 0.460 |
Why?
|
Secondary Prevention | 1 | 2020 | 1530 | 0.460 |
Why?
|
Diabetes Complications | 1 | 2020 | 1359 | 0.450 |
Why?
|
Prevalence | 8 | 2023 | 15226 | 0.440 |
Why?
|
Kidney Diseases | 1 | 2023 | 2149 | 0.420 |
Why?
|
Lipids | 1 | 2022 | 3305 | 0.390 |
Why?
|
Medicare | 4 | 2022 | 6566 | 0.380 |
Why?
|
Health Status Disparities | 1 | 2021 | 1797 | 0.350 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3336 | 0.330 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3158 | 0.330 |
Why?
|
Costs and Cost Analysis | 3 | 2022 | 1681 | 0.320 |
Why?
|
Hospital Mortality | 1 | 2021 | 5317 | 0.300 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 3068 | 0.300 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 25043 | 0.270 |
Why?
|
Humans | 40 | 2024 | 744343 | 0.240 |
Why?
|
Obesity | 4 | 2023 | 12745 | 0.240 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6487 | 0.230 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2022 | 59 | 0.210 |
Why?
|
Registries | 1 | 2018 | 8089 | 0.210 |
Why?
|
Health Services Accessibility | 4 | 2022 | 5137 | 0.200 |
Why?
|
Colchicine | 1 | 2021 | 243 | 0.190 |
Why?
|
Hospitals, Rural | 1 | 2021 | 172 | 0.180 |
Why?
|
Adult | 12 | 2023 | 214055 | 0.180 |
Why?
|
Male | 17 | 2023 | 350118 | 0.170 |
Why?
|
Cause of Death | 2 | 2021 | 3584 | 0.170 |
Why?
|
Drug Labeling | 1 | 2021 | 233 | 0.170 |
Why?
|
Hospitals, Urban | 1 | 2021 | 499 | 0.170 |
Why?
|
Hypotension, Orthostatic | 1 | 2022 | 255 | 0.170 |
Why?
|
Health Expenditures | 2 | 2022 | 2348 | 0.170 |
Why?
|
Female | 17 | 2023 | 380194 | 0.160 |
Why?
|
Middle Aged | 13 | 2023 | 213383 | 0.160 |
Why?
|
Risk Factors | 6 | 2023 | 72290 | 0.160 |
Why?
|
Anticoagulants | 2 | 2024 | 4599 | 0.160 |
Why?
|
Health Services Misuse | 1 | 2020 | 243 | 0.160 |
Why?
|
Aged | 15 | 2023 | 163280 | 0.150 |
Why?
|
Awards and Prizes | 1 | 2022 | 375 | 0.150 |
Why?
|
Biphenyl Compounds | 1 | 2021 | 913 | 0.150 |
Why?
|
Hospital Administration | 1 | 2021 | 353 | 0.150 |
Why?
|
Cholesterol, HDL | 1 | 2023 | 1814 | 0.140 |
Why?
|
Hospitals, Teaching | 1 | 2021 | 1179 | 0.140 |
Why?
|
Neuromuscular Diseases | 1 | 2019 | 248 | 0.140 |
Why?
|
Reimbursement, Incentive | 1 | 2021 | 540 | 0.130 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2019 | 259 | 0.130 |
Why?
|
Warfarin | 1 | 2024 | 1496 | 0.130 |
Why?
|
Ventricular Function, Left | 3 | 2023 | 3670 | 0.130 |
Why?
|
Endpoint Determination | 1 | 2018 | 601 | 0.130 |
Why?
|
Diabetic Nephropathies | 1 | 2022 | 984 | 0.130 |
Why?
|
Minority Groups | 1 | 2022 | 1223 | 0.120 |
Why?
|
Patients | 1 | 2021 | 900 | 0.120 |
Why?
|
Reference Standards | 1 | 2018 | 1025 | 0.120 |
Why?
|
Blood Pressure Determination | 1 | 2018 | 634 | 0.120 |
Why?
|
Needs Assessment | 1 | 2020 | 1147 | 0.120 |
Why?
|
Drug Utilization | 1 | 2020 | 1183 | 0.120 |
Why?
|
Cholesterol | 1 | 2022 | 2917 | 0.110 |
Why?
|
Health Services Needs and Demand | 1 | 2021 | 1411 | 0.110 |
Why?
|
Hypoglycemic Agents | 2 | 2022 | 2872 | 0.110 |
Why?
|
Confidence Intervals | 1 | 2018 | 2971 | 0.100 |
Why?
|
Cardiology | 1 | 2022 | 1668 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2018 | 9959 | 0.100 |
Why?
|
Time Factors | 4 | 2021 | 40075 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2864 | 0.090 |
Why?
|
Antiviral Agents | 1 | 2021 | 2987 | 0.090 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2018 | 1004 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 7913 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1671 | 0.080 |
Why?
|
Prognosis | 2 | 2019 | 29063 | 0.080 |
Why?
|
Public Health | 1 | 2021 | 2603 | 0.080 |
Why?
|
Insulin | 1 | 2022 | 6580 | 0.080 |
Why?
|
Patient Readmission | 1 | 2022 | 3114 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2020 | 2376 | 0.080 |
Why?
|
Liver Cirrhosis | 1 | 2017 | 1863 | 0.070 |
Why?
|
Databases, Factual | 2 | 2019 | 7729 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2021 | 3923 | 0.070 |
Why?
|
Insurance, Health | 1 | 2019 | 2494 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2021 | 63114 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12788 | 0.060 |
Why?
|
Cohort Studies | 3 | 2022 | 40561 | 0.060 |
Why?
|
Acute Coronary Syndrome | 1 | 2018 | 2337 | 0.060 |
Why?
|
Age Factors | 2 | 2019 | 18370 | 0.060 |
Why?
|
Body Mass Index | 1 | 2022 | 12720 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10397 | 0.060 |
Why?
|
Comorbidity | 1 | 2018 | 10388 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12354 | 0.060 |
Why?
|
Naphthyridines | 1 | 2022 | 118 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39050 | 0.050 |
Why?
|
Stroke Volume | 2 | 2023 | 5007 | 0.040 |
Why?
|
Physicians | 1 | 2018 | 4567 | 0.040 |
Why?
|
Young Adult | 2 | 2023 | 56430 | 0.040 |
Why?
|
Neprilysin | 1 | 2021 | 439 | 0.040 |
Why?
|
Survival of Motor Neuron 1 Protein | 1 | 2019 | 64 | 0.040 |
Why?
|
Hospitals | 2 | 2022 | 3952 | 0.040 |
Why?
|
Albuminuria | 1 | 2022 | 682 | 0.040 |
Why?
|
American Heart Association | 1 | 2022 | 1056 | 0.040 |
Why?
|
Algorithms | 1 | 2018 | 13881 | 0.040 |
Why?
|
Risk | 2 | 2021 | 9687 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11727 | 0.040 |
Why?
|
Risk Assessment | 1 | 2018 | 23338 | 0.030 |
Why?
|
Patient Care | 1 | 2022 | 640 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 1959 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 924 | 0.030 |
Why?
|
Stroke | 1 | 2018 | 9981 | 0.030 |
Why?
|
Aftercare | 1 | 2020 | 866 | 0.030 |
Why?
|
Patient Admission | 1 | 2021 | 1380 | 0.030 |
Why?
|
Area Under Curve | 1 | 2018 | 1654 | 0.030 |
Why?
|
Disease Progression | 2 | 2021 | 13284 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2018 | 867 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6171 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2569 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3527 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7149 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6459 | 0.020 |
Why?
|
Hemorrhage | 1 | 2020 | 3461 | 0.020 |
Why?
|
Medicaid | 1 | 2022 | 2736 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3679 | 0.020 |
Why?
|
Patient Discharge | 1 | 2020 | 3313 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9146 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9849 | 0.020 |
Why?
|
Incidence | 1 | 2021 | 20947 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13408 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 77449 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16365 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2018 | 4468 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10262 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 25625 | 0.010 |
Why?
|
Infant | 1 | 2019 | 35136 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 57776 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 41006 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 29786 | 0.010 |
Why?
|
Child | 1 | 2019 | 77709 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 85781 | 0.010 |
Why?
|
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_